Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
11 September 2023
UPC Structure – local, regional and central divisions and Court of Appeal, Judges & Languages
1 June 2023
The Unified patent court and unitary patent – An introduction
19 May 2023
The IP in AI – What you need to know
6 October 2022
Near enough is good enough: Full Federal Court of Australia revisits construction of “about” in patent claim
19 August 2022
Penalties for breaches of Australian competition and consumer law set to increase
25 March 2022
First things first: Full Federal Court clarifies the law on patent term extensions
28 January 2021
THE IMPACT OF THE NEW ITALIAN FOREIGN INVESTMENTS RULES ON THE PHARMA SECTOR
13 November 2020
IP in a time of crisis – What does pharma have to do with a low-carbon future?
